论文部分内容阅读
急性脑梗死是神经系统常见病及多发病,特别是在高原地区和东北地区等高寒地区较为多发,致残率及致死率较高,特别是大面积脑梗死,对于超早期脑梗死治疗中,溶栓治疗是比较有效的治疗手段[1],笔者近年来采用尿激酶动脉注射溶栓治疗超早期急性脑梗死18例,现行期疗效回顾性分析如下。1.资料与方法1.1临床资料本次对超急性期进行动脉溶栓的患者均来自我院2013年10月至2014年10月进行诊治的18例急性脑梗死患者,临床症状以偏瘫及偏身
Acute cerebral infarction is a common disease of the nervous system and frequently-occurring disease, especially in alpine areas such as plateau and northeastern regions are more frequent, high morbidity and mortality, especially large-area cerebral infarction, for the treatment of ultra-early cerebral infarction, Thrombolytic therapy is more effective treatment [1], in recent years, I use urokinase arterial thrombolysis in the treatment of ultra-early acute cerebral infarction in 18 cases, the current efficacy of a retrospective analysis is as follows. 1. Materials and Methods 1.1 Clinical data of the ultra-acute arterial thrombolysis patients from our hospital from October 2013 to October 2014 for diagnosis and treatment of 18 patients with acute cerebral infarction, clinical symptoms of hemiplegia and partial body